FDA Investigator Sheri S Oliver
Sheri S Oliver has conducted inspections on 51 sites in 10 countries as of 08 Jan 2018. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
51
Last Inspection Date:
08 Jan 2018
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Australia,
United States of America,
Belgium,
Korea (Republic of),
Bulgaria,
Argentina,
China,
Colombia,
Canada,
Spain
FDA Investigators that have inspected at least one site in common with Sheri S Oliver:
Anthony J Grace,
Anthony S Puckett,
April R Bowen,
Barbara D Wright,
Bonita S Chester,
Brandy D Brown,
Brentley S Collins,
Carol F Robinson,
CDR Rochelle B Young, RPh, MSA,
Christina H Owens,
Claudele S Razo,
Cordelia J Brammer,
Dana M Klimavicz,
David T Glover,
Davis,
Dawn C Olenjack,
Dellarese L Herbert,
Derek C Price,
Edecia A Richards,
Eric W Anderson,
Esra Toussaint,
Fabian Nchaparro Rodriguez,
Gabriel R Mclemore,
Gamal A Norton,
Hai Lient Phung,
Ingrid A Zambrana,
Janet B Gray,
Jannet M Peroti,
Jessica Fields,
John D Lloyd,
Joseph A Seitz, III,
Jude C Dikes,
Kassa Ayalew, MD,
Katrina B Mosley Sloan,
Kellie R Riggs,
Kenny R Robinson,
Kimberly Cdelk Brooks,
Lakecha N Lewis,
Lakisha N Morton,
Lance Mde Souza, MBA,
Lareese K Thomas,
Lawrence Thomas,
Lawton W Lum,
Leslie W Gilbert,
Lorenzo Jones,
Lori A Gioia,
Lydia S Chan,
Maida Henesian (NMI),
Marie K Kinkade,
Matthew G Brown,
Miaja Umaedi,
Michelle D Haamid,
Myla D Chapman,
Nicholas M Smith,
Nicole C Victoria, PhD,
Nicole M Bell,
Patricia F Hudson,
Paul M Kawamoto,
Peter R Lenahan,
Phillip D Kronstein, MD,
Randy L Clarida,
Robin N Goins,
Sandra C Lawrence,
Sandra S Saniga,
Sarah C Pichette,
Seneca D Toms,
Sereen Gmorgan Murray,
Sergio Chavez (NMI),
Simone M Edmonson,
Stephanie E Hubbard,
Stephanie Harrell,
Theresa L Stewart,
Timothy C Grome,
Tyrico K English,
Vanessa E Coulter,
Viviana Matta,
William P Tonkins
Sheri S Oliver's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2009 | EIR | Woodson, Grattan, M.D. - EIR, 2009-04-17 |
January, 2018 | FDA 483 | Conrado Estol, M.D. - Form 483, 2018-01-12 |
September, 2010 | FDA 483 | Benjamin D. Gold, M.D. - Form 483, 2010-09-30 |
April, 2009 | FDA 483 | Woodson, Grattan, M.D. - Form 483, 2009-04-17 |
August, 2010 | EIR | Augusta University IRB- Medical College Of Georgia Human Assurance Committee - EIR, 2010-08-10 |
February, 2012 | EIR | Brian Bortnick - EIR, 2012-02-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more